Development of Functional Materials for Fluorescent Detection of Biological Substances

被引:0
作者
Suzuki, Yoshio [1 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Hlth & Med Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan
关键词
fluoreacent detection; proteins; glycocunjugates; neurotransmitters; ENDOTHELIAL GROWTH-FACTOR; HIGHLY-SENSITIVE DETECTION; SELECTIVE DETECTION; DESIGN; PROBE; PEPTIDE; SILVER; SERUM; VEGF;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In recent years, research on disease-related substances has made remarkable progress, and it has become clear that they play an important roles in cancer, immunoreceptors, fertilization, development/differentiation, infectious diseases, biopharmacy development, and the like. Since the amount of disease-related marker substances present in the living body is very small, the development of a new evaluation technique is required. The authors have developed new compounds that have both a fluorescent substance with high environmental responsiveness, which was originally developed, and a substance (peptide, etc.) that has a high affinity for disease-related substances, neurotransmitters, and the like. Furthermore, when the organic fluorescent substance was modified on the surface of an inorganic material, such as magnetic particles, and various concentrations of the disease-related substance were added, a change in the fluorescence intensity and high-sensitivity detection of the disease-related substance by using magnetic beads were achieved. In this paper, we introduce such materials developed by the author with an emphasis on the viewpoint of analytical chemistry.
引用
收藏
页码:681 / 690
页数:10
相关论文
共 33 条
  • [1] The Physiology, Signaling, and Pharmacology of Dopamine Receptors
    Beaulieu, Jean-Martin
    Gainetdinov, Raul R.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 182 - 217
  • [2] Bowen Michael T, 2018, Curr Top Behav Neurosci, V35, P269, DOI 10.1007/7854_2017_17
  • [3] Sweet silver: A formaldehyde-free silver staining using aldoses as developing agents, with enhanced compatibility with mass spectrometry
    Chevallet, Mireille
    Luche, Sylvie
    Diemer, Helene
    Strub, Jean-Marc
    Van Dorsselaer, Alain
    Rabilloud, Thierry
    [J]. PROTEOMICS, 2008, 8 (23-24) : 4853 - 4861
  • [4] Choi NS, 2004, J BIOCHEM MOL BIOL, V37, P298
  • [5] Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site
    Fairbrother, WJ
    Christinger, HW
    Cochran, AG
    Fuh, C
    Keenan, CJ
    Quan, C
    Shriver, SK
    Tom, JYK
    Wells, JA
    Cunningham, BC
    [J]. BIOCHEMISTRY, 1998, 37 (51) : 17754 - 17764
  • [6] Vascular endothelial growth factor: Basic science and clinical progress
    Ferrara, N
    [J]. ENDOCRINE REVIEWS, 2004, 25 (04) : 581 - 611
  • [7] Oxytocin prevents the increase of cocaine-related responses produced by social defeat
    Ferrer-Perez, Carmen
    Castro-Zavala, Adriana
    Angel Lujan, Miguel
    Filarowska, Joanna
    Ballestin, Raul
    Minarro, Jose
    Valverde, Olga
    Rodriguez-Arias, Marta
    [J]. NEUROPHARMACOLOGY, 2019, 146 : 50 - 64
  • [8] Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors
    Holzer, G
    Obermair, A
    Koschat, M
    Preyer, O
    Kotz, R
    Trieb, K
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (06): : 601 - 604
  • [9] STRUCTURE AND EXPRESSION OF A HUMAN OXYTOCIN RECEPTOR
    KIMURA, T
    TANIZAWA, O
    MORI, K
    BROWNSTEIN, MJ
    OKAYAMA, H
    [J]. NATURE, 1992, 356 (6369) : 526 - 529
  • [10] The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter
    Klubo-Gwiezdzinska, Joanna
    Junik, Roman
    Kopczynska, Ewa
    Juraniec, Olga
    Kardymowicz, Hanna
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (04) : 521 - 527